June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
ADAMTS4 activity and TIMP3 levels are modulated in trabecular meshwork cells with decreased hyaluronan synthesis
Author Affiliations & Notes
  • Kate Keller
    Ophthalmology, Casey Eye Insitute - OHSU, Portland, OR
  • Yong-Feng Yang
    Ophthalmology, Casey Eye Insitute - OHSU, Portland, OR
  • Ying Ying Sun
    Ophthalmology, Casey Eye Insitute - OHSU, Portland, OR
  • Ted Acott
    Ophthalmology, Casey Eye Insitute - OHSU, Portland, OR
  • Footnotes
    Commercial Relationships Kate Keller, None; Yong-Feng Yang, None; Ying Ying Sun, None; Ted Acott, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3546. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kate Keller, Yong-Feng Yang, Ying Ying Sun, Ted Acott; ADAMTS4 activity and TIMP3 levels are modulated in trabecular meshwork cells with decreased hyaluronan synthesis. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3546.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Accumulating evidence supports a role for hyaluronan (HA) in regulating matrix metalloproteinase (MMP) expression, cellular localization and activity. Here, we analyzed ADAMTS4 (a disintegrin and metalloproteinase with thrombospondin motifs-4) mRNA expression, proteins levels and enzyme activity in trabecular meshwork (TM) cells with depleted HA. The amount of TIMP3, the tissue inhibitor of ADAMTS4, was also assessed.

Methods: Two methods were used to reduce HA concentration: 1 mM 4-methylumbelliferone (4MU) or previously characterized short hairpin RNAi silencing (shRNA) lentivirus targeted to each individual HA synthase (HAS) gene (shHAS1, shHAS2 and shHAS3). Vehicle control and shControl, which does not target any known gene, were also included. Primary porcine TM cells were subjected to 4MU treatment for 48 or 72 hours. For infection, lentivirus was incubated for 3 days and then cells were changed to serum-free media for a further 48 or 72 hours. ADAMTS4 mRNA levels were determined by quantitative RT-PCR and protein levels in RIPA cell lysates were analyzed by Western immunoblotting. A fluorometric ADAMTS4 activity assay was used to quantitate enzyme activity. Cells were fixed and immunostained for confocal microscopy.

Results: ADAMTS4 mRNA levels decreased with all treatments, but protein levels were not significantly altered. ADAMTS4 activity was significantly decreased with all treatments at 48 and 72 hours. TIMP3 protein levels were reduced with shHAS infection, but increased with 4MU treatment. TIMP3 was immunolocalized in the cytoplasm and at PILS (podosome or invadopodia-like structures), areas of focal ECM degradation. TIMP3 also colocalized with clusters of ADAMTS4-stained vesicles. There seemed to be a higher degree of colocalization of TIMP3 and ADAMTS4 in 4MU-treated cells.

Conclusions: ADAMTS4 activity appears to be dependent on HA concentration. Since HA concentration decreases in aged eyes and is reduced even further in POAG patients, the ability of TM cells to focally remodel ECM via ADAMTS4 may be compromised, which in turn could adversely affect aqueous outflow.

Keywords: 735 trabecular meshwork • 519 extracellular matrix • 661 proteoglycans/glycosaminoglycans  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.